Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Cell Cycle (Georgetown, Tex.)|October 19, 2020
miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6Rong Cao, Keqi Wang, Manmei Long, et al.
Frontiers in Immunology|April 1, 2026
Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysisYonghong Zhao, Bokun Chen, Xiaojuan Zhao, et al.
Medical Image Analysis|May 16, 2025
REPAIR: Reciprocal assistance imputation-representation learning for glioma diagnosis with incomplete MRI sequencesChuixing Wu, Jincheng Xie, Fangrong Liang, et al.
Nano Letters|February 26, 2021
Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic ChemotherapyFangzhou Yu, Yalan Tu, Shiwei Luo, et al.
Cancer Management and Research|February 11, 2021
Multiphase Contrast-Enhanced CT-Based Machine Learning Models to Predict the Fuhrman Nuclear Grade of Clear Cell Renal Cell CarcinomaShengsheng Lai, Lei Sun, Jialiang Wu, et al.
Small Methods|October 22, 2025
Graphene-Bridged Multicrystalline TiO<sub>2</sub> Networks: Bimetallic Pinning Enhanced Electrochemical PerformanceXin Tian, Ze Liu, Shuyi Yang, et al.
International Journal of Biological Macromolecules|January 12, 2020
Redox-responsive nanoparticles from disulfide bond-linked poly-(N-ε-carbobenzyloxy-l-lysine)-grafted hyaluronan copolymers as theranostic nanoparticles for tumor-targeted MRI and chemotherapyHuikang Yang, Yingling Miao, Lipeng Chen, et al.
Acta Biomaterialia|February 15, 2024
Nanoparticle-mediated blockade of CXCL12/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomicsRuili Wei, Jiamin Li, Wanxian Lin, et al.
NPJ Digital Medicine|May 4, 2026
Multimodal deep learning model for multiclass classification of renal tumorsShiwei Luo, Quan Quan, Ruimeng Yang, et al.
BMC Medical Imaging|December 30, 2025
Machine learning-based radiomics from multiparametric MRI for predicting aggressive pathology in clear cell renal cell carcinomaJie Zhan, Lei Sun, Enming Cui, et al.
Pageof 9